Is intensive treatment to lower lipid levels beneficial to older patients after acute coronary syndrome?

What The Study Did: In this secondary analysis of a randomized clinical trial, researchers examined the association of age with the benefit of intensive treatment to lower lipid levels with a combination therapy of simvastatin and ezetimibe compared to treatment with simvastatin alone after acute coronary syndrome in older patients.

Authors: Richard G. Bach, M.D., of Washington University School of Medicine in St. Louis, is the corresponding author.

(doi:10.1001/jamacardio.2019.2306)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###

Media advisory: The full study, commentary and podcast are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time: https://jamanetwork.com/journals/jamacardiology/fullarticle/2738104?guestAccessKey=b98d7a70-e094-48e9-ad30-afe6fa5bbc3d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071719

Media Contact
JAMA Network Media Relations

[email protected]

Comments